Aehr Test Systems (NASDAQ:AEHR) Director Sells $836,220.00 in Stock

Key Points

• Director Rhea Posedel sold 5,973 AEHR shares at an average price of $140, generating $836,220; she retained 381,989 shares worth approximately $53.5 million.
• AEHR shares rose to $134.06 and remain near their 52-week high, while analysts maintain a consensus “Buy” rating with an average price target of $136.67; Jefferies recently initiated coverage with a $175 target.
• Growth prospects are supported by a $22 million AI-processor testing order, record quarterly bookings of $60.7 million and a backlog of roughly $100.6 million, though insider selling and the stock’s elevated valuation present risks.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) Director Rhea Posedel sold 5,973 shares of Aehr Test Systems stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $140.00, for a total value of $836,220.00. Following the completion of the sale, the director owned 381,989 shares in the company, valued at approximately $53,478,460. This represents a 1.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Aehr Test Systems Price Performance

Aehr Test Systems stock traded up $10.76 during mid-day trading on Friday, reaching $134.06. 3,300,655 shares of the company traded hands, compared to its average volume of 2,436,568. The firm's 50 day moving average price is $92.12 and its 200 day moving average price is $71.00. The firm has a market capitalization of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a 52-week low of $16.38 and a 52-week high of $147.40.

Analyst Ratings Changes

A number of equities research analysts have weighed in on AEHR shares. Zacks Research upgraded shares of Aehr Test Systems from a "hold" rating to a "strong-buy" rating in a report on Friday, July 17th. Weiss Ratings downgraded Aehr Test Systems from a "sell (d)" rating to a "sell (e+)" rating in a report on Wednesday, July 29th. Wall Street Zen raised Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Lake Street Capital reiterated a "buy" rating and issued a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Jefferies Financial Group started coverage on Aehr Test Systems in a research note on Thursday. They issued a "buy" rating and a $175.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Aehr Test Systems has a consensus rating of "Buy" and an average target price of $136.67.

More Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Hedge Funds Weigh In On Aehr Test Systems

Large investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Aehr Test Systems in the fourth quarter worth $25,000. Advocate Investing Services LLC bought a new stake in Aehr Test Systems during the second quarter valued at about $26,000. Sunbelt Securities Inc. purchased a new position in shares of Aehr Test Systems in the third quarter valued at about $27,000. State of Wyoming purchased a new position in shares of Aehr Test Systems in the second quarter valued at about $28,000. Finally, KBC Group NV purchased a new position in shares of Aehr Test Systems in the first quarter valued at about $30,000. Hedge funds and other institutional investors own 69.69% of the company's stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source